The Grand Challenge

It is known that more than 1.5 million Americans were diagnosed with cancer during 2009, and half a million have died (Cancer Statistics 2009, ACS). In spite of considerable effort, there has been limited success in reducing per capita deaths from cancer since 1950. This calls for a paradigm shift in the understanding, detection, and intervention of the evolution of cancer from a single cell to tumor scale.

In response to this challenge the M-CNTC has assembled a preeminent interdisciplinary team of researchers and educators across the University of Illinois and clinical collaborators in the Midwest to train the next generation of engineers, physical scientists, and biologists to address the challenge of understanding, managing, diagnosing, and treating cancer using the most recent advancements in nanotechnology.

M-CNTC Trainee Research Highlights (PDF)

 

Clinical Collaborators